Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
PHARMA EVIDENCE ApS
APS
Active
CVR 34586519
Sommervej 9, 3520
Farum
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2012 · 14 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
PHARMA EVIDENCE ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
1M
1M
1M
0M
0M
2021: 0M
0M
2021
2022: 1M
1M
2022
2023: 0M (-100% vs 2022)
0M
-100%
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
EBITDA
DKK millions
0M
0M
-1M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: -1M
-1M
2023
2024: 0M (+100% vs 2023)
0M
2024
2025: 0M
0M
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
64
-158
-428
552
196
Staff expenses
-2
-27
-381
-412
-644
EBITDA
62
-185
-810
140
-448
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
62
-185
-810
140
-448
Net financials
-5
5
10
-5
6
Profit before tax
62
-180
-799
135
-442
Tax
-0
-0
-3
-63
-0
Net profit
62
-180
-796
197
-442
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
282
212
784
1.268
1.320
Equity
134
72
252
1.048
851
Long-term debt
0
0
0
0
0
Short-term debt
148
140
532
220
469
Total debt
148
140
532
220
469
Financial ratios
5-year trend
EBITDA margin (of gross profit)
97,2 %
This company
2021
2025
Equity ratio
47,7 %
This company
38,2 %
Market median
This company
Market median
25% above market
2021
2025
Return on equity
46,2 %
This company
18,4 %
Market median
This company
Market median
151% above market
2021
2025
Net profit margin (of gross profit)
97,1 %
This company
2021
2025
Asset turnover (of gross profit)
0,23×
This company
2021
2025
Debt / equity
1,10×
This company
0,62×
Market median
This company
Market median
77% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on PHARMA EVIDENCE ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
